Germline pathogenic variants in neuroblastoma patients are enriched in <i>BARD1</i> and predict worse survivalJung Kim, Sharon J. Diskin, Laura E. Egolf et al.|JNCI Journal of the National Cancer Institute|2023Cited by 28